NEVVI Medicare utilization intelligence

Geography — Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg (Q5124) in Medicare, the United States

Geography · Q5124 · National · CY2024
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where Q5124 is billed · every state market

Every state market that bills this code, by services, each linked to its own market page.

← Back to the market overview